COMMUNIQUÉS West-GlobeNewswire

-
Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available
23/06/2018 -
Healthcare Special Opportunities Fund Announces June 2018 Quarterly Distribution
22/06/2018 -
Analogic Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners
22/06/2018 -
Altimmune Restructures Financing Agreement
22/06/2018 -
Imagin Provides Further Detail on Kilmer Lucas Engagement
22/06/2018 -
DBV Technologies Announces Results of its 2018 Ordinary and Extraordinary General Meeting and the Appointment of Joan Schmidt as Executive Vice President, General Counsel
22/06/2018 -
DBV Technologies annonce les résultats de son Assemblée générale ordinaire et extraordinaire 2018 et la nomination de Joan Schmidt au poste d'Executive Vice President, Secrétaire Générale
22/06/2018 -
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
22/06/2018 -
ALPHA PRO TECH, LTD. ANNOUNCES ADDITIONAL $2 MILLION EXPANSION TO SHARE REPURCHASE PROGRAM
22/06/2018 -
Natus Medical Announces Preliminary Results of 2018 Annual Meeting of Stockholders
22/06/2018 -
Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record
22/06/2018 -
Matrix Medical Network to Present at 2018 RISE Quality Leadership Summit
22/06/2018 -
Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in Boston
22/06/2018 -
EncounterCare Solutions Inc. Announces CyberFuels New fuel shipments commence in Quebec, Canada
22/06/2018 -
Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018
22/06/2018 -
Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day
22/06/2018 -
Ordinary General Meeting of Shareholders of Probiodrug AG
22/06/2018 -
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
22/06/2018 -
Matinas BioPharma Announces Closing of $8.0 Million Public Offering
22/06/2018
Pages